A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate KarXT + KarX-EC as a treatment for psychosis associated with Alzheimer\'s disease.
Epistemonikos ID: fc64742c68eaab5c26756d803d7efba51a58c672
First added on: Apr 29, 2025